JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung CancersSean P. Pitroda, Nikolai N. Khodarev|Molecular Cancer Therapeutics|2018Cited by 23